{"disease":{"id":"nonresectable-bile-duct-cancer","name":"nonresectable bile duct cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03679338","title":"Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}